Home
Our Mission
About CytoDyn
- Meet CytoDyn
Our Science
Pipeline
Our Team
Publications
Newsroom
- Press Releases
Investors
Contact

Press Releases

Investors

Overview
Investor FAQs
Investor Update Calls
Annual Meeting of Stockholders
Warrant Exercise Inquiries
Restricted Stock Inquiries
News / Events
Company Info
Financial Info
Stock Data
SEC Filings
Governance

News / Events
Overview
Press Releases
In The News
IR Calendar
Email Alerts

Year

CytoDyn Announces Leadership Transition Plan to Support Regulatory Approval and Commercialization of Leronlimab

Jan 25, 2022 6:06pm EST

1
2
3
4
5

Email Alerts
Tear Sheet
Contacts
RSS News Feed

© 2025 CytoDyn Inc. All Rights Reserved.

Privacy Policy Disclaimer Sitemap